Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1s9d | AFB | Cytohesin-2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1s9d | AFB | Cytohesin-2 | / | 1.000 | |
| 1s9d | AFB | ADP-ribosylation factor 1 | / | 1.000 | |
| 1r8q | AFB | Cytohesin-2 | / | 0.584 | |
| 1r8q | AFB | ADP-ribosylation factor 1 | / | 0.584 | |
| 1re0 | AFB | ADP-ribosylation factor 1 | / | 0.522 | |
| 1re0 | AFB | ARF guanine-nucleotide exchange factor 1 | / | 0.522 | |
| 4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.476 | |
| 4ktf | 1TM | Cytochrome P450 | / | 0.474 | |
| 3byz | H11 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.472 | |
| 3wd9 | QPC | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.471 | |
| 3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.470 | |
| 5bp9 | SAH | Putative methyltransferase protein | / | 0.467 | |
| 5kf2 | ACO | Predicted acetyltransferase | / | 0.467 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.466 | |
| 5kf9 | ACO | Predicted acetyltransferase | / | 0.465 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.465 | |
| 4wdb | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.463 | |
| 5kf8 | ACO | Predicted acetyltransferase | / | 0.463 | |
| 4b4w | 9L9 | Bifunctional protein FolD | / | 0.460 | |
| 3hu2 | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.458 | |
| 1u1d | 181 | Uridine phosphorylase | 2.4.2.3 | 0.457 | |
| 2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.456 | |
| 1b87 | ACO | Aac(6')-Ii protein | / | 0.455 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.455 | |
| 7cat | NDP | Catalase | 1.11.1.6 | 0.454 | |
| 2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 4a2z | VIQ | Glycylpeptide N-tetradecanoyltransferase | / | 0.453 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.453 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.453 | |
| 2geu | COK | Pantothenate kinase | 2.7.1.33 | 0.452 | |
| 1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.451 | |
| 3o73 | O73 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.451 | |
| 3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.451 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
| 4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.451 | |
| 3u9f | CLM | Chloramphenicol acetyltransferase | 2.3.1.28 | 0.450 | |
| 4ktk | KTK | Cytochrome P450 | / | 0.450 | |
| 8cat | NDP | Catalase | 1.11.1.6 | 0.450 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.450 | |
| 1dgf | NDP | Catalase | 1.11.1.6 | 0.449 | |
| 2f98 | NGV | Aklanonic acid methyl ester cyclase AcmA | 5.5.1.23 | 0.449 | |
| 3g5h | YTT | Mycocyclosin synthase | 1.14.21.9 | 0.449 | |
| 5kgj | ACO | Predicted acetyltransferase | / | 0.449 | |
| 2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.448 | |
| 2ouy | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.448 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.448 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.448 | |
| 5dp2 | NAP | CurF | / | 0.447 | |
| 5kf1 | ACO | Predicted acetyltransferase | / | 0.447 | |
| 5kgh | ACO | Predicted acetyltransferase | / | 0.447 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.447 | |
| 1v7a | FRC | Adenosine deaminase | 3.5.4.4 | 0.446 | |
| 2ntv | P1H | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.445 | |
| 3cr7 | PPS | Adenylyl-sulfate kinase | 2.7.1.25 | 0.445 | |
| 4da6 | GA2 | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.445 | |
| 2ycz | I32 | Beta-1 adrenergic receptor | / | 0.445 | |
| 2w4q | CBW | Prostaglandin reductase 2 | 1.3.1.48 | 0.444 | |
| 1dlr | MXA | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 2zb8 | IMN | Prostaglandin reductase 2 | 1.3.1.48 | 0.443 | |
| 3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.443 | |
| 1kce | CB3 | Thymidylate synthase | / | 0.442 | |
| 4ips | 1G4 | Mycocyclosin synthase | 1.14.21.9 | 0.442 | |
| 4ktl | 1CQ | Cytochrome P450 | / | 0.442 | |
| 5fm7 | ADP | RuvB-like helicase | / | 0.442 | |
| 2wsa | 646 | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
| 3nhk | VAP | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.441 | |
| 3s7a | 684 | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 4b4v | L34 | Bifunctional protein FolD | / | 0.441 | |
| 4ia1 | BIV | Vitamin D3 receptor A | / | 0.441 | |
| 4qoh | STL | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.441 | |
| 2rh1 | CAU | Beta-2 adrenergic receptor | / | 0.441 | |
| 1db1 | VDX | Vitamin D3 receptor | / | 0.440 | |
| 1fml | RTL | Retinol dehydratase | / | 0.440 | |
| 1jtq | LY3 | Thymidylate synthase | / | 0.440 | |
| 2ore | SAH | DNA adenine methylase | 2.1.1.72 | 0.440 | |
| 3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.440 | |
| 3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.440 | |
| 4at0 | FAD | Possible succinate dehydrogenase | / | 0.440 | |
| 4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4g48 | PZB | Mycocyclosin synthase | 1.14.21.9 | 0.440 | |
| 4n82 | FMN | Ribonucleotide reductase (NrdI family protein), putative | / | 0.440 | |
| 4zvm | DM2 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.440 |